Influence of various tubal surgeries to serum antimullerian hormone level and outcome of the subsequent IVF-ET treatment

References

• Coughlan C, Li TC. Surgical management of tubal disease and infertility. Obstet Gynaecol Reprod Med 2009;19:4
   Google Scholar
• National Institute for Clinical Excellence (NICE). Guideline 11. Fertility: assessment and treatment for people with fertility problems. Clinical Guideline. London: RCOG Press; 2004
   Google Scholar
• Gelbaya TA, Nardo LG, Fitzgerald CT, et al. Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges. Fertil Steril 2006; 85:1464–8
   PubMed Web of Science ®Google Scholar
• Orvieto R, Saar-Ryss B, Morgante G, et al. Does salpingectomy affect the ipsilateral ovarian response to gonadotropin during in vitro fertilization-embryo transfer cycles? Fertil Steril 2011;95:1842–4
   PubMed Web of Science ®Google Scholar
• Tiras B, Noyan V, Ozdemir H, et al. The changes in ovarian hormone levels and ovarian artery blood flow rate after laparoscopic tubal sterilization. Eur J Obstet Gynecol Reprod Biol 2001;99:219–21
   PubMedGoogle Scholar
• Hakverdi AU, Taner CE, Erden AC, et al. Changes in ovarian function after tubal sterilization. Adv Contracep 1994;10:51–6
   PubMedGoogle Scholar
• Rojansky N, Halbreich U. Prevalence and severity of premenstrual changes after tubal sterilization. J Reprod Med 1991;36:551–5
   PubMedGoogle Scholar
• Kelekci S, Yorgancioglu Z, Yilmaz B, et al. Effect of tubal ligation on ovarian reserve and the ovarian stromal blood supply. Aust NZ J Obstet Gynaecol 2004;44:449–51
   PubMed Web of Science ®Google Scholar
• Vigier B, Picard JY, Tran D, et al. Production of antimullerian hormone: another homology between sertoli and granulose cells. Endocrinology 1984;114:1315–20
   PubMed Web of Science ®Google Scholar
• Kevenaar ME, Meerasahib MF, Kramer P, et al. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 2006;47:3228–34
   Google Scholar
• Fanchin R, Schonauer LM, Righini C, et al. Serum anti mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003;18:323–7
   PubMed Web of Science ®Google Scholar
• Mcllveen M, Skull JD, Ledger WL. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod 2007;22:778–85
   PubMedGoogle Scholar
• De Vet A, Laven JS, de Jong FH, et al. Anti-mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357–62
   PubMed Web of Science ®Google Scholar
• Van Rooij IA, Broekmans FJ, te Velde ER, et al. Serum anti-mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065–71
   PubMed Web of Science ®Google Scholar
• Fanchin R, Taieb J, Mendez Lozano DH, et al. High reproducibility of serum antimullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 2005;20:923–7
   PubMed Web of Science ®Google Scholar
• La Marca A, Stabile G, Carducci Artenisio A, et al. Serum anti-mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006; 21:3103–7
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7
   PubMed Web of Science ®Google Scholar
• Practice Committee of American Society for Reproductive Medicine. The role of tubal reconstructive surgery in the era of assisted reproductive technologies. Fertil Steril 2008;90:S250–3
   PubMedGoogle Scholar
• Donaghay M, Lessey BA. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med 2007;25:461–75
   PubMed Web of Science ®Google Scholar
• Tremellen KP, Kolo M, Gilmore A, et al. Anti-mullerian hormone as a marker of ovarian reserve. Aust NZ J Obstet Gynaecol 2005;45:20–4
   PubMed Web of Science ®Google Scholar
• Ficicioglu C, Kutlu T, Baglam E, et al. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 2006;85:592–6
   PubMed Web of Science ®Google Scholar
• Hazout A, Bouchard P, Seifer DB, et al. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 2004;82:1323–9
   PubMed Web of Science ®Google Scholar
• Lekamge DN, Barry M, Kolo M, et al. Anti-mullerian hormone as a predictor of IVF outcome. Reprod Biomed Online 2007;14:602–10
   PubMed Web of Science ®Google Scholar
• Strandell A. The influence of hydrosalpinx on IVF and embryo transfer: a review. Hum Reprod Update 2000;6:387–95
   PubMed Web of Science ®Google Scholar
• Copperman AB, Wells V, Luna M, et al. Presence of hydrosalpinx correlated to endometrial inflammatory response in vivo. Fertil Steril 2006; 86:972–6
   PubMed Web of Science ®Google Scholar
• Seli E, Kayisli UA, Cakmak H, et al. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Hum Reprod 2005;20:3012–17
   PubMed Web of Science ®Google Scholar
• Bildirici I, Bukulmez O, Ensari A, et al. A prospective evaluation of the effect of salpingectomy on endometrial receptivity in cases of women with communicating hydrosalpinges. Hum Reprod 2001;16:2422–6
   PubMedGoogle Scholar
• Daftary GS, Kayisli U, Seli E, et al. Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx. Fertil Steril 2007;87:367–72
   PubMed Web of Science ®Google Scholar
• Johnson NP, Mak W, Sowter MC. Laparoscopic salpingectomy for women with hydrosalpinges enhances the success of IVF: a Cochrane review. Hum Reprod 2002;17:543–8
   PubMedGoogle Scholar